20LBA What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses

Claire L. Vale, Larysa Rydzewska, Jayne F. Tierney, Laurence Albigès, Noel W. Clarke, David J. Fisher, Karim Fizazi, Nicholas D. James, Malcolm D. Mason, Max Parmar, C. Sweeney, Matthew R. Sydes, Bertrand Tombal, Sarah Burdett
European Journal of Cancer
September 1, 2015
10.1016/s0959-8049(16)31941-4
Cited by 5

Abstract

Related Papers

No related papers found

Powered by citation graph analysis